AzTrials
AzTrials

Osteoarthritis, KneeVIKEPNCT04618016

Evaluation of Medium Cross-linked Polyethylene With and Without Vitamin E for Total Knee Arthroplasty

An observational study of Osteoarthritis, Knee and Arthritis, Rheumatoid, run by Aesculap AG at 8 sites in 2 countries.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Prospective, randomized, single-blind, multinational, long-term study for the evaluation of the clinical outcome, oxidation profile and wear analysis of medium cross-linked Polyethylene with and without Vitamin E for total knee arthroplasty Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
UHMWPE with Vitamin E and UHMWPE without Vitamin E
Type of treatment
Medical device
How many people
605 participants
Where
8 sitesin 2 countries
Study dates
8 Mar 2021to Oct 2034
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: multicentric

Who may be able to join

  • Indication for a total knee replacement with a mobile-bearing UC or PS inlay
  • Written informed consent for participating at the clinical study
  • Willingness and mental ability to participate at the long-term follow-up examinations

Who cannot join

  • Patient age < 18 and > 80 years
  • Pregnancy
  • High risk patients (ASA class >3)

Trial locations and contacts

8 sites in 2 countries.

8 sites in 2 countries

Germany6 sites
  • Park-Klinik Weißensee

    Berlin, 13086

  • Lukas Krankenhaus

    Bünde, North Rhine-Westphalia, 32257

  • Waldkliniken Eisenberg

    Eisenberg, 07607

  • Brüderhaus Koblenz

    Koblenz, Rhineland-Palatinate, 56073

  • Krankenhaus Reinbek, St. Adolf Stift

    Reinbek, 21465

  • Universitätsklinikum Rostock, Klinik für Orthopädie

    Rostock, 18057

Other trials in Germany

France2 sites
  • CHU Amiens-Picardie

    Amiens, 80054

  • Hôpital Sud - CHU de Grenoble

    Échirolles, Isere, 38130

Other trials in France

About this study

Official title: Prospective, Randomized, Single-blind, Multinational, Long-term Study for the Evaluation of the Clinical Outcome, Oxidation Profile and Wear Analysis of Medium Cross-linked Polyethylene With and Without Vitamin E for Total Knee Arthroplasty

Prospective, randomized, single-blind, multinational, long-term study for the evaluation of the clinical outcome, oxidation profile and wear analysis of medium cross-linked Polyethylene with and without Vitamin E for total knee arthroplasty

Being tested
UHMWPE with Vitamin E, UHMWPE without Vitamin E
Keywords
Total Knee Arthroplasty, Range of motion, Treatment outcome, Ultrahighmolecular Weight Polyethylene with Vitamin E
Medical subject headings
Osteoarthritis, Knee, Arthritis, Rheumatoid, Intra-Articular Fractures, Joint Instability, Genu Valgum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • UHMWPE with Vitamin EDevice

    e.motion Pro (PS and UC) with MXE gliding surface

  • UHMWPE without Vitamin EDevice

    e.motion Pro (PS and UC) with β-PE gliding surface

Study groups in NCT04618016
Study groupRoleWhat they receive
With Vitamin ENot described
Receives: Device: UHMWPE with Vitamin E
Without Vitamin ENot described
Receives: Device: UHMWPE without Vitamin E

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical Outcome measured with the KSS [performance]

    The KSS is an examiner-administrated standard clinical evaluation tool reporting results for patients undergoing TKA. It separates findings in the operated knee (kKSS) score from findings related to the patient's function (fKSS), which might be affected by co-morbidities. The two sub-scores are reported separately ranging from 0 points (worst result) to 100 points (best results), as well as summarized score, total KSS. Final grading of total KSS results Scores of 160 to 200 will be rated as excellent, 140 to 159 as good, 120 to 139 as fair, and less than 120 as poor.

    Measured: 10 years postoperatively

Secondary outcomes (8)
  1. Survival rate

    Kaplan-Meier Analysis is a standard statistical method to describe the survival of human subjects or medical products over a defined time period. The revision-free survival rate is the performance indicator of the product under investigation and confirms the clinical outcome of the knee prosthesis. Information on survival of the implant will be collected until the last follow-up of the study patients took place.

    Measured: until the last follow-up at 10 years postoperatively

  2. Progress of Clinical Outcome [Oxford Knee Score] compared to baseline

    The Oxford Knee Score is a reliable 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing total knee replacement. It is short, reproducible, valid and sensitive to clinically important changes over time. Each of the 12 questions on the OKS is scored in the same way with the score decreasing as the reported symptoms increase (i.e. become worse). All questions are laid out with response categories denoting least (or no) symptoms to the left of the page (scoring 4) and those representing greatest severity lying on the right hand side (scoring 0), as detailed for question 1 below. This method, when summed, produces overall scores running from 0 to 48 with 48 being the best outcome, (to convert from the 60-12 system to the 0-48 system and vice versa subtract the score from 60).

    Measured: Preoperatively, 3 months, 12 months, 3 years, 5 years, 7 years, 10 years

  3. Quality of Life [EQ-5D-5L]

    EQ-5D is a standardized 5-dimension 5-level measure of the health status and is developed by the EuroQol Group in order to have a simple and generic measure for clinical and economic assessment. Instructions for the user are directly included into the questionnaire and it consists of two pages. One cover five different dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression) and the other one the EQ visual Analogue Scale (EQ-VAS). The VAS scale records the self rated health status of the patient from the level "the worst health you can imagine" to "the best health you can imagine".

    Measured: Preoperatively, 3 months, 12 months, 5 years, 10 years

  4. Comparison of Radiographic evaluation over time

    Imaging will be used to evaluate the implant status as well as device condition and potential presence of device-related Adverse Events including fracture, wear, loosening or radiolucencies.

    Measured: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years

  5. Comparison of Radiographic alignment over time

    Alignment (femoral-knee baseline angle, tibial-knee baseline angle, femoral-tibial angle (mechanical))

    Measured: baseline (assessed at discharge from hospital up to 10 days postoperatively); 3 months; 12 months; 5 years; 10 years

  6. Oxidation profile and wear analysis of available retrievals

    Available retrievals of explanted investigational products will be analysed by the biomechanical laboratory of the sponsor. Therefore any retrieval has to be returned to the Sponsor's facility after its revision in order to perform these analyses. Special focus of theses analyses are the oxidation profile, the wear behaviour, the mechanics and the cumulative linear abrasion of these retrievals. These measurements can further analyse the in-vivo performance of the device of the reference and investigational product

    Measured: During the course of the study up to 10 years postoperatively

  7. Further analysis of patients having a revision of the primary implant

    In case a patient requires the revision of the primary implanted knee prosthesis, additional information on the revision surgery shall be collected. The reason for revision together with the clinical symptoms shall be documented. Further examinations (e.g. arthroscopy) prior to the revision and the date of revision surgery is to be documented. If pre revision radiographs are taken as part of the clinical routine, the results of the radiographic analysis shall be documented in the respective CRF.

    Measured: During the course of the study up to 10 years postoperatively

  8. (Serious) Adverse Events

    During the course of the study, any upcoming intra- or postoperative (serious) adverse device events or effects related or not related to the product under investigation, will be documented. The total number of AEs will be summarized and further evaluated by the sponsor and reported according to local legislation and necessity. Recorded complications will be categorized and analyzed in order to assess the safety of the investigational product.

    Measured: During the course of the study up to 10 years postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Nov 2020
  2. Study start8 Mar 2021
  3. Primary completion31 Dec 2024
  4. Study completionOct 2034 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
605 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04618016
Sponsor's protocol ID
AAG-O-H-1906
Acronym
VIKEP
Status last verified
Oct 2026
First submitted
27 Oct 2020
Last updated
20 Oct 2026
Results posted
No

Publications

  • Maier K, Selig M, Haddouche A, Haunschild M, Hauschild O, Khalili I, Kirschberg J, Lutter C, Menges M, Mertl P, Niemeier A, Rubens-Duval B, Mittelmeier W. Vitamin E-enriched medium cross-linked polyethylene in total knee arthroplasty (VIKEP): clinical outcome, oxidation profile, and wear analysis in comparison to standard polyethylene-study protocol for a randomized controlled trial. Trials. 2024 Jan 5;25(1):27. doi: 10.1186/s13063-023-07811-1.

    PubMed 38183062

Questions about this trial

What is this clinical trial studying?

An observational study of Osteoarthritis, Knee and Arthritis, Rheumatoid, run by Aesculap AG at 8 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 20 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in Germany, France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical Outcome measured with the KSS [performance] (time frame: 10 years postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04618016, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in